| Financial Year |
September 30 2019 |
| Monetary Funds |
3,317,127.02 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
55,806,695.08 |
| Advances to Suppliers |
4,314,739.54 |
| Other Receivables |
4,960,051.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,321,874.05 |
| Total Current Assets |
73,720,487.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
34,086,750.91 |
| Investment Properties |
-- |
| Fixed Assetes |
9,571,374.37 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,298,818.72 |
| R&D expenses |
4,051,440.99 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
109,392,006.11 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
285,830,391.10 |
| Total Assets |
359,550,878.61 |
| Short-Term Loans |
210,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
102,179,424.23 |
| Accounts Received In Advance |
5,042,461.65 |
| Employee Compensation Payable |
24,947,103.01 |
| Taxes Payable |
1,994,768.97 |
| Interest Payable |
15,616,896.90 |
| Dividend Payable |
88,684.57 |
| Other payables |
154,310,977.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,502,076.94 |
| Other Current Liabilities |
7,349,411.69 |
| Sub-Total of Current Liabilities |
533,326,224.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
472,385,837.78 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
484,159,706.81 |
| Total Liabilities |
1,017,485,930.85 |
| Paid-In Capital(Or Share Stock) |
327,585,793.00 |
| Capital Surplus |
400,885,010.40 |
| Surplus Reserve |
55,005,185.78 |
| LESS:Treasury Stock |
33,832,176.69 |
| Undistributed Profits |
-1,374,976,966.13 |
| Minority Stockholder's Interest |
-24,485,132.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-633,449,919.59 |
| Owner's Equity（Stockholder's Equity） |
-657,935,052.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
359,550,878.61 |
